Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI
The increased sensitivity of mpUS imaging to higher GG lesions and adverse histopathological factors, along with moderate agreement with mpMRI, suggest that mpUS has the potential to guide biopsy targeting of mpMRI-visible lesions or serve as an alternative biopsy-targeting approach when mpMRI is unavailable or clinically contraindicated.
Authors
- Srinath Kotamarti (ORCID: https://orcid.org/0000-0003-1392-9102)
- Thomas J. Polascik (ORCID: https://orcid.org/0000-0003-3666-1372)
- Spencer R. Moavenzadeh (ORCID: https://orcid.org/0009-0002-0513-8116)
- Eric S. Adams (ORCID: https://orcid.org/0000-0002-2954-1973)
- Sriram Deivasigamani (ORCID: https://orcid.org/0000-0002-1790-9558)
- Mark L. Palmeri (ORCID: https://orcid.org/0000-0001-8995-0050)
- Derek Y. Chan (ORCID: https://orcid.org/0000-0003-1816-5455)
- Kathryn R. Nightingale (ORCID: https://orcid.org/0000-0003-0960-4495)
Institutions
- Duke University (US)
- Duke Medical Center (US)
- Duke University Hospital (US)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1186/s40644-025-00874-0
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- U.S. Department of Defense
- Siemens Medical Solutions USA
- National Institutes of Health